Table 1.
Baseline Demographic and Clinical Characteristics of 280 Patients
| Baseline Characteristic | Patients, No. (%)a | P Valueb | |||
|---|---|---|---|---|---|
| All (n = 280) | Definite Tuberculosis (n = 72) |
Probable Tuberculosis (n = 65) |
No Tuberculosis (n = 143) |
||
| Age, median (IQR), y | 39 (32–48) | 38 (32–48) | 40 (35.5–47.5) | 39 (32–48) | .83 |
| Male sex | 175 (62.5) | 42 (58.3) | 48 (73.8) | 85 (59.4) | .99 |
| Enrolled at Siriraj Hospital | 123 (43.9) | 41 (56.9) | 20 (30.8) | 62 (43.4) | .08 |
| Inpatient setting | 229 (81.8) | 61 (84.7) | 52 (80.0) | 116 (81.1) | .64 |
| ART at enrollment | 29 (10.4) | 3 (4.2) | 8 (12.3) | 18 (12.6) | .09 |
| CD4 cell count, median (IQR), cells/μL | 33 (12–68) | 41 (12–86) | 33 (13–72.5) | 32 (12–61) | .15 |
| CD4 cell count | |||||
| <50/μL | 183 (65.4) | 42 (58.3) | 41 (63.1) | 100 (69.9) | .12 |
| 50–100/μL | 57 (20.4) | 15 (20.8) | 15(23.1) | 27 (18.9) | .87 |
| >100/μL to 200/μL | 40 (14.3) | 15 (20.8) | 9 (13.8) | 16 (11.2) | .09 |
| Presenting symptoms | |||||
| Weight loss | 245 (87.5) | 65 (90.3) | 55 (84.6) | 125 (87.4) | .69 |
| Chronic cough | 174 (62.1) | 47 (65.3) | 35 (53.8) | 92 (64.3) | >.99 |
| Lymphadenopathy | 35 (12.5) | 14 (19.4) | 5 (7.7) | 16 (11.2) | .15 |
| Specimens, no. | |||||
| Total | 778 | 197 | 187 | 394 | … |
| Sputum | 367 | 88 | 79 | 200 | … |
| Blood | 240 | 54 | 60 | 126 | … |
| Extrapulmonary | 171 | 55 | 48 | 68 | … |
| Deathc | 41 (15.8) | 5 (7.2) | 11 (18.6) | 25 (18.9) | .03 |
Abbreviations: ART, antiretroviral therapy; IQR, interquartile range.
aData represent no. (%) of patients unless otherwise indicated.
b P values for comparison between definite and no-tuberculosis groups, with differences considered significant at P < .05.
cTwenty patients with no outcome data were excluded from the data on deaths, including 3 from the definite tuberculosis, 6 from the probable tuberculosis, and 11 from the no-tuberculosis group.